Acquisition linkage Key Surgical is now part of STERIS, signaling an integration of instrument reprocessing and infection prevention capabilities with a broader hospital supply ecosystem. This suggests sales opportunities via cross-sell of Steris infection control products and complementary procedural solutions to existing Key Surgical customers.

Endoscopy expansion Recent acquisitions extended endoscopy product offerings. Leverage this to propose enhanced reprocessing consumables and endoscopy workflow solutions to facilities expanding GI and endoscopic procedures.

Surgical workflow focus Emphasis on surgical instrument reprocessing and OR efficiency presents a pathway to bundle consumables, sterilization services, and education programs aimed at reducing turnaround times and improving positive surgical outcomes.

Mid-market potential With 51–200 employees and Revenues in the $10–25M range, Key Surgical sits in a mid-market niche where targeted solutions for hospitals and ambulatory surgery centers can drive value, especially in facilities seeking scalable reprocessing and instrument access.

Tech-enabled growth Adoption of modern analytics and web tech indicates readiness for digital engagement and customer education programs. Propose digital onboarding, subscription-based consumables, and online training to increase adoption and recurring revenue.